During this month's #gyncsm chat (Wednesday, July 8, 2020 at 9pm ET) we will discuss gynecologic cancer research presented at this year's SGO and virtual ASCO meetings as well as learn about How to Read Scientific Posters.
To lead the second part of the chat, we are pleased to have Kimberly Richardson @KDRichardson924, creator of the Survivors Advising Scientists Educational Program (SASEP), as well as the SASEP Program presenters @UICMSTP, graduate students Benjamin Gordon, Tova Bergsten and Casey Blaha from the University of Illinois at Chicago joining us.
They will share information about SASEP and then provide participants with tips on how to read a scientific poster. We'll use posters from #ASCO20 that provide gyn cancer information as examples.
We hope you can join us on Wednesday, July 8th at 9pm ET (8pm CT, 6pm PT) for this informative chat.
Topic Questions
T1: Whether or not a woman should have a second surgery for ovarian cancer continues to be debated. What does the most recent research suggest and what do women need to consider?T2: PARP inhibitors took center stage again in the care of women with ovarian cancer. With one study reaching its goal and one that did not, what do women need to know?T3: What is the "Survivors Advising Scientists Educational Program”? What led to its development?T4: What topics do the SASEP modules cover? Where can patients go to learn more about the program?T5: Let’s talk about the module on “How to Read a Scientific Poster”. What are the main points patients/advocates should consider when reading a scientific poster presented at an annual meeting like ASCO or SGO?T6: This poster from #ASCO2020 reports on the low rate of BRCA testing for patients with ovarian cancer. Using this as an example, can you walk us through how an advocate/patient/survivor could read and understand it?T7: Here is another poster from #ASCO2020 discussing early-line treatment for endometrial cancer. Using the tips from your module, what are the key points to learn from this poster?
Dee
#gyncsm co-founder
No comments:
Post a Comment